Churchill Capital XI Files S-1/A for $300M SPAC IPO

TL;DR

**Avoid CCXIW; the sponsor's massive dilution and inherent conflicts of interest make this a high-risk bet for public shareholders.**

AI Summary

Churchill Capital Corp XI (CCXIW) filed an S-1/A on December 11, 2025, for an initial public offering of 30,000,000 units at $10.00 per unit, aiming to raise $300,000,000. Each unit comprises one Class A ordinary share and one-tenth of one warrant, with each whole warrant exercisable at $11.50 per share. The company is a blank check company, or SPAC, with no selected business combination target. The sponsor, Churchill Sponsor XI LLC, an affiliate of M. Klein and Company, LLC, will purchase 500,000 private placement units for $5,000,000. The sponsor also owns 11,500,000 Class B ordinary shares, acquired for a nominal price of $0.002 per share, which will convert to Class A shares and represent 25% of outstanding shares post-IPO. Public shareholders face significant dilution from the sponsor's founder shares and private placement warrants. The company has 24 months (or up to 27 months with an LOI) to complete an initial business combination, or it will liquidate, redeeming public shares at a per-share price from the trust account. The filing highlights substantial conflicts of interest due to the sponsor's low cost basis and potential for significant profit even if the target business declines in value.

Why It Matters

This S-1/A filing signals Churchill Capital Corp XI's intent to raise $300 million for a SPAC, offering investors a chance to participate in a future, yet-to-be-identified business combination. However, the significant dilution from the sponsor's founder shares, acquired at a nominal $0.002 per share, creates a substantial risk for public investors, as the sponsor could profit even if the target company underperforms. This structure, common in SPACs, raises concerns about alignment of interests between sponsors and public shareholders, potentially impacting the broader market's perception of SPAC viability. Competitively, this SPAC enters a crowded market, where investor scrutiny on sponsor incentives and deal quality is intensifying.

Risk Assessment

Risk Level: high — The risk level is high due to the significant dilution potential and inherent conflicts of interest. The sponsor, Churchill Sponsor XI LLC, acquired 11,500,000 Class B ordinary shares for a nominal $25,000 (or $0.002 per share), which will convert to 25% of the company's outstanding shares post-IPO. This creates an incentive for the sponsor to complete any business combination, even if it's unprofitable for public shareholders, as they stand to make a substantial profit from their low-cost basis. Additionally, the company's officers and directors have fiduciary duties to other entities, potentially diverting attractive business opportunities away from Churchill Capital Corp XI.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the terms of this SPAC. Given the substantial dilution from founder shares and potential conflicts of interest, a prudent investor should likely avoid this offering or wait until a definitive business combination target is announced and its financials can be rigorously assessed. The current structure heavily favors the sponsor.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

$300,000,000

revenue Growth

N/A

Key Numbers

• $300,000,000 — Total IPO offering size (Represents the capital Churchill Capital Corp XI aims to raise from the public offering of 30,000,000 units.)
• 30,000,000 — Number of units offered (Each unit is priced at $10.00, contributing to the total offering size.)
• $10.00 — Offering price per unit (The price at which each unit, consisting of one Class A ordinary share and one-tenth of one warrant, is sold.)
• $11.50 — Warrant exercise price (The price at which each whole warrant entitles the holder to purchase one Class A ordinary share.)
• 500,000 — Private placement units purchased by sponsor (Churchill Sponsor XI LLC will purchase these units for $5,000,000 simultaneously with the IPO.)
• $5,000,000 — Aggregate purchase price for private placement units (The total amount paid by the sponsor for its private placement units.)
• 11,500,000 — Class B ordinary shares owned by sponsor (These founder shares were purchased for an aggregate of $25,000, representing significant potential dilution.)
• $0.002 — Nominal purchase price per Class B share (The extremely low price paid by the sponsor for founder shares, highlighting the potential for substantial profit.)
• 25% — Sponsor's ownership of ordinary shares post-IPO (The percentage of outstanding ordinary shares the sponsor will own on an as-converted basis upon consummation of the IPO.)
• 24 months — Time to complete initial business combination (The period within which Churchill Capital Corp XI must complete a business combination, or face liquidation.)

Key Players & Entities

• Churchill Capital Corp XI (company) — Registrant for S-1/A filing
• Churchill Sponsor XI LLC (company) — Sponsor of Churchill Capital Corp XI
• M. Klein Associates Inc. (company) — Managing member of Churchill Sponsor XI LLC
• M. Klein and Company, LLC (company) — Affiliate of Churchill Sponsor XI LLC
• Jay Taragin (person) — Agent for Service for Churchill Capital Corp XI
• Douglas S. Ellenoff, Esq. (person) — Legal counsel from Ellenoff Grossman & Schole LLP
• Stuart Neuhauser, Esq. (person) — Legal counsel from Ellenoff Grossman & Schole LLP
• Joel L. Rubinstein, Esq (person) — Legal counsel from White & Case LLP
• Daniel E. Nussen, Esq. (person) — Legal counsel from White & Case LLP
• Citigroup Global Markets Inc. (company) — Underwriter for the IPO

FAQ

Risk Factors

• Dilution from Sponsor Shares and Warrants [high — financial]: The sponsor, Churchill Sponsor XI LLC, owns 11,500,000 Class B ordinary shares acquired at a nominal price of $0.002 per share. These shares convert to Class A shares and represent 25% of outstanding shares post-IPO. Additionally, the sponsor purchases 500,000 private placement units at $10.00 per unit. This structure creates significant dilution for public shareholders, as the sponsor's low cost basis allows for substantial profit even with a declining target business value.
• Limited Time to Complete Business Combination [high — operational]: Churchill Capital Corp XI has a 24-month period (extendable to 27 months with an LOI) to complete an initial business combination. Failure to do so will result in liquidation, with public shares redeemed at a per-share price from the trust account. This tight timeline creates pressure to find and close a deal, potentially leading to suboptimal choices.
• SPAC Regulatory Scrutiny [medium — regulatory]: The Securities and Exchange Commission (SEC) has increased its scrutiny of SPACs, particularly concerning disclosures, sponsor economics, and potential conflicts of interest. Any changes in regulatory guidance or enforcement actions could impact the company's ability to complete a business combination or the terms thereof.
• Trust Account Limitations and Redemptions [medium — financial]: Public shareholders have redemption rights if they do not approve of the business combination or if the company liquidates. The trust account, initially funded with $300,000,000 from the IPO, will be used for redemptions. The amount available for redemptions is reduced by permitted withdrawals for working capital and taxes, and by dissolution expenses ($100,000) upon liquidation.
• Conflicts of Interest [high — legal]: The sponsor's significant ownership of founder shares at a nominal cost, coupled with private placement warrants, creates inherent conflicts of interest. The sponsor may be incentivized to pursue a transaction that benefits them financially, even if it is not in the best long-term interest of public shareholders.
• Market Volatility and IPO Window [medium — market]: The success of the IPO and the ability to complete a business combination are subject to prevailing market conditions and investor sentiment towards SPACs. A downturn in the broader market or specific sectors could impact the valuation of potential targets and the overall feasibility of the SPAC's strategy.

Industry Context

Churchill Capital Corp XI operates within the Special Purpose Acquisition Company (SPAC) industry, which has seen significant growth and subsequent increased regulatory scrutiny. The market for SPACs is highly competitive, with numerous blank check companies seeking to identify and acquire targets. Trends include a focus on specific sectors, longer completion timelines, and evolving sponsor economics to align incentives.

Regulatory Implications

The filing is subject to SEC regulations governing IPOs and SPACs. Increased scrutiny on SPAC disclosures, particularly regarding sponsor compensation, conflicts of interest, and forward-looking statements, poses a risk. Compliance with evolving accounting standards and potential changes in SPAC regulations could impact the company's operations and ability to complete a business combination.

What Investors Should Do

1. Carefully review the sponsor's economic interests and potential conflicts of interest.
2. Assess the dilution impact from sponsor shares and warrants.
3. Monitor the company's progress in identifying and completing a business combination within the 24-month timeframe.
4. Understand the terms and implications of redemption rights.

Key Dates

• 2025-12-10: Filing of S-1/A Amendment No. 1 — Provides updated information and disclosures for the initial public offering, including details on the offering structure, sponsor economics, and risk factors.
• 2025-12-11: Initial Public Offering (IPO) Planned — Churchill Capital Corp XI aims to raise $300,000,000 by selling 30,000,000 units at $10.00 per unit.
• 2027-12-10: Completion Window Expiration (24 months) — The deadline for Churchill Capital Corp XI to complete its initial business combination. Failure to do so will trigger liquidation and redemption of public shares.

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that raises capital through an IPO to acquire an existing company. (Churchill Capital Corp XI is a SPAC with no pre-selected target.)

Units

Securities offered in the IPO, each comprising one Class A ordinary share and one-tenth of a warrant. (The primary offering vehicle for raising capital in the IPO.)

Warrants

Securities giving the holder the right, but not the obligation, to purchase a Class A ordinary share at a specified price ($11.50) within a certain timeframe. (Warrants are included in the units and private placement units, and represent potential future dilution.)

Sponsor

The entity that organizes and invests in the SPAC, typically receiving founder shares and private placement warrants. (Churchill Sponsor XI LLC is the sponsor, with significant economic interest and potential conflicts.)

Founder Shares (Class B)

Shares typically held by the sponsor, acquired at a nominal price, which convert to Class A shares. (The sponsor's 11,500,000 Class B shares represent substantial potential dilution.)

Trust Account

An account holding the IPO proceeds, which are typically invested in U.S. Treasury securities, to be used for the business combination or redemptions. (The source of funds for redemptions if no business combination is completed.)

Business Combination

The acquisition or merger of the SPAC with a target company. (The sole purpose of the SPAC; must be completed within the specified timeframe.)

Redemption Rights

The right of public shareholders to sell their shares back to the company for cash, typically at the IPO price plus accrued interest, if they do not approve of the business combination or if the SPAC liquidates. (A key protection for public shareholders, but also a factor in SPAC liquidity and deal certainty.)

Year-Over-Year Comparison

This is an S-1/A filing, representing an amendment to the initial S-1 registration statement. As such, it does not represent a prior year's financial performance. The key focus is on the structure of the IPO, the economics of the sponsor, and the risks associated with a blank check company seeking a business combination within a defined timeframe. New risks related to SPAC market dynamics and regulatory scrutiny are highlighted.

Key Financial Figures

• $300,000,000 — E L I M I N A R Y P R O S P E C T U S $300,000,000 Churchill Capital Corp XI 30,000,00
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $1,000,000 — irements, subject to an annual limit of $1,000,000, and to pay our taxes ("permitted withd
• $100,000 — n (less permitted withdrawals and up to $100,000 of interest income to pay dissolution e
• $5,000,000 — nit, for an aggregate purchase price of $5,000,000 (including if the underwriter's over -a
• $600,000 — ring or thereafter, we will repay up to $600,000 in loans made to us by our sponsor to c
• $30,000 — er of our sponsor in an amount equal to $30,000 per month for office space, utilities a
• $1,500,000 — our initial business combination, up to $1,500,000 of such loans may be convertible into u
• $0.15 — 283,500,000 ____________ (1) Includes $0.15 per unit, or $4,500,000 (or $5,175,000
• $4,500,000 — ______ (1) Includes $0.15 per unit, or $4,500,000 (or $5,175,000 if the underwriter's ove
• $5,175,000 — ludes $0.15 per unit, or $4,500,000 (or $5,175,000 if the underwriter's overallotment opti
• $0.40 — erwriting discount. Also includes up to $0.40 per unit, or $12,000,000 (or $13,575,00
• $12,000,000 — Also includes up to $0.40 per unit, or $12,000,000 (or $13,575,000 if the underwriter's ov
• $13,575,000 — p to $0.40 per unit, or $12,000,000 (or $13,575,000 if the underwriter's overallotment opti

Filing Documents

• ea0251141-05.htm (S-1/A) — 4276KB
• 0001213900-25-120290.txt ( ) — 5793KB
• ccix-20251210.xsd (EX-101.SCH) — 8KB
• ccix-20251210_def.xml (EX-101.DEF) — 11KB
• ccix-20251210_lab.xml (EX-101.LAB) — 101KB
• ccix-20251210_pre.xml (EX-101.PRE) — 61KB
• ea0251141-05_htm.xml (XML) — 285KB

From the Filing

As filed with the United States Securities and Exchange Commission on December 10, 2025. Registration No. 333-291626 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________ AMENDMENT No. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________ Churchill Capital Corp XI (Exact Name of Registrant as Specified in its Charter) __________________________ Cayman Islands 6770 86-1959629 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (IRS Employer Identification Number) 640 Fifth Avenue, 14 th Floor New York, NY 10019 Telephone: (212) 380-7500 (Address, including Zip Code, and Telephone Number, including Area Code, of Registrant's Principal Executive Offices) __________________________ Jay Taragin c/o Churchill Capital Corp XI 640 Fifth Avenue, 14 th Floor New York, NY 10019 Telephone: (212) 380-7500 (Name, Address, including Zip Code, and Telephone Number, including Area Code, of Agent for Service) __________________________ Copies to: Douglas S. Ellenoff, Esq. Stuart Neuhauser, Esq. Ellenoff Grossman & Schole LLP 1345 Avenue of the Americas New York, NY 10105 (212) 370-1300 Bradley Kruger Ogier (Cayman) LLP 89 Nexus Way, Camana Bay Grand Cayman Cayman Islands KY1-9009 (345) 949-9876 Joel L. Rubinstein, Esq Daniel E. Nussen, Esq. White & Case LLP 1221 Avenue of the Americas New York, NY 10020 (212) 819 -8200 __________________________ Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. Table of Contents The information contained in this preliminary prospectus is not complete and may be changed. No securities may be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities, and it is not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted. P R E L I M I N A R Y P R O S P E C T U S $300,000,000 Churchill Capital Corp XI 30,000,000 Units __________________________ Churchill Capital Corp XI is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated a

View Full Filing

View this S-1/A filing on SEC EDGAR